- Home
- HHS vs COCH Comparison
HHS vs COCH Comparison
Compare HHS & COCH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HHS
- COCH
- Stock Information
- Founded
- HHS 1923
- COCH 1995
- Country
- HHS United States
- COCH United States
- Employees
- HHS N/A
- COCH N/A
- Industry
- HHS Advertising
- COCH Blank Checks
- Sector
- HHS Consumer Discretionary
- COCH Finance
- Exchange
- HHS Nasdaq
- COCH Nasdaq
- Market Cap
- HHS 30.3M
- COCH 31.6M
- IPO Year
- HHS N/A
- COCH N/A
- Fundamental
- Price
- HHS $3.39
- COCH $1.72
- Analyst Decision
- HHS
- COCH Strong Buy
- Analyst Count
- HHS 0
- COCH 2
- Target Price
- HHS N/A
- COCH $9.25
- AVG Volume (30 Days)
- HHS 29.5K
- COCH 28.4K
- Earning Date
- HHS 08-07-2025
- COCH 08-11-2025
- Dividend Yield
- HHS N/A
- COCH N/A
- EPS Growth
- HHS N/A
- COCH N/A
- EPS
- HHS N/A
- COCH N/A
- Revenue
- HHS $181,355,000.00
- COCH $212,000.00
- Revenue This Year
- HHS $6.54
- COCH $5.93
- Revenue Next Year
- HHS N/A
- COCH $17.69
- P/E Ratio
- HHS N/A
- COCH N/A
- Revenue Growth
- HHS N/A
- COCH N/A
- 52 Week Low
- HHS $3.24
- COCH $1.21
- 52 Week High
- HHS $8.52
- COCH $3.99
- Technical
- Relative Strength Index (RSI)
- HHS 32.88
- COCH 60.10
- Support Level
- HHS $3.70
- COCH $1.56
- Resistance Level
- HHS $4.03
- COCH $1.80
- Average True Range (ATR)
- HHS 0.29
- COCH 0.11
- MACD
- HHS -0.02
- COCH 0.02
- Stochastic Oscillator
- HHS 3.54
- COCH 60.00
About HHS Harte-Hanks Inc.
Harte-Hanks Inc is a customer experience company. The Company operates three business segments: Marketing Services; Customer Care; and Fulfillment & Logistics Services. The company has a geographic presence in the United States and Other countries. The majority of the revenue is earned from the United States.
About COCH Envoy Medical Inc.
Envoy Medical Inc is a hearing health company focused on providing medical technologies. It is dedicated to pushing hearing technology beyond the status quo to provide patients with improved access, usability, independence and quality of life. The Company has one reportable segment: hearing. The hearing segment derives revenue from the sale of the Esteem FI-AMEI implants and replacement components to Esteem FI-AMEI implants.